Intraoperative autologous transfusion and oncologic outcomes in liver transplantation for hepatocellular carcinoma: a propensity matched analysis

HPB

Volumn 24, Issue 3, 2022, Pages 379-385

  Sutton, Thomas L ^a   Pasko, Jennifer ^b   Kelly, Gabrielle ^c   Maynard, Erin ^a   Connelly, Christopher ^a   Orloff, Susan ^a   Enestvedt, C Kristian ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b SACRED HEART MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD TRANSFUSION; CANCER RECURRENCE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTRAOPERATIVE AUTOLOGOUS TRANSFUSION; INTRAOPERATIVE PERIOD; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MODEL FOR END STAGE LIVER DISEASE SCORE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PROPENSITY SCORE; PROSPECTIVE STUDY; RECURRENCE FREE SURVIVAL; SCORING SYSTEM; TREATMENT OUTCOME; ADVERSE EVENT; LIVER TUMOR; RETROSPECTIVE STUDY; TUMOR RECURRENCE;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES;

EID: 85110464740     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1016/j.hpb.2021.06.433     Document Type: Article

References (32)

1. Akinyemiju, T., Abera, S., Ahmed, M., Alam, N., Alemayohu, M.A., Allen, C., et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015. JAMA Oncol 3 (2017 Dec 1), 1683–1691.
2. White, D.L., Thrift, A.P., Kanwal, F., Davila, J., El-Serag, H.B., Incidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012. Gastroenterology 152 (2017 Mar), 812–820.e5.
3. Byam, J., Renz, J., Millis, J.M., Liver transplantation for hepatocellular carcinoma. Hepatobiliary Surg Nutr 2 (2013 Feb), 22–30.
4. Shen, J.Y., Li, C., Wen, T.F., Yan, L.N., Li, B., Wang, W.T., et al. Liver transplantation versus surgical resection for hcc meeting the milan criteria: a propensity score analysis. Medicine (Baltim), 95, 2016 Dec, e5756.
5. Shen, J.Y., Li, C., Wen, T.F., Yan, L.N., Li, B., Wang, W.T., et al. Transplantation versus hepatectomy for hcc beyond the milan criteria: a propensity score analysis. Int J Surg 44 (2017 Aug), 33–42.
6. Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996 Mar 14), 693–699.
7. Tripodi, A., Mannucci, P.M., The coagulopathy of chronic liver disease. N Engl J Med 365 (2011 Jul 14), 147–156.
8. Kornberg, A., Witt, U., Kornberg, J., Ceyhan, G.O., Mueller, K., Friess, H., et al. Prognostic impact of intraoperative blood loss in liver transplant patients with advanced hepatocellular carcinoma. Anticancer Res 36 (2016 Oct), 5355–5364.
9. Ashworth, A., Klein, A.A., Cell salvage as part of a blood conservation strategy in anaesthesia. Br J Anaesth 105 (2010 Oct), 401–416.
10. Tawes, R.L. Jr., DuVall, T.B., Autotransfusion cell-saver and plasma saver. Surg Technol Int I (1991 Nov), 110–111.
11. Esper, S.A., Waters, J.H., Intra-operative cell salvage: a fresh look at the indications and contraindications. Blood Transfus 9 (2011 Apr), 139–147.
12. Klein, A.A., Bailey, C.R., Charlton, A.J., Evans, E., Guckian-Fisher, M., McCrossan, R., et al. Association of anaesthetists guidelines: cell salvage for peri-operative blood conservation 2018. Anaesthesia 73 (2018 Sep), 1141–1150.
13. Latif, M.J., Tan, K.S., Molena, D., Huang, J., Bott, M.J., Park, B.J., et al. Perioperative blood transfusion has a dose-dependent relationship with disease recurrence and survival in patients with non-small cell lung cancer. J Thorac Cardiovasc Surg 157 (2019 Jun), 2469–2477.e10.
14. Beynon, J., Davies, P.W., Billings, P.J., Channer, J.L., Protheroe, D., Umpleby, H.C., et al. Perioperative blood transfusion increases the risk of recurrence in colorectal cancer. Dis Colon Rectum 32 (1989 Nov), 975–979.
15. Deeb, A.P., Aquina, C.T., Monson, J.R.T., Blumberg, N., Becerra, A.Z., Fleming, F.J., Allogeneic leukocyte-reduced red blood cell transfusion is associated with postoperative infectious complications and cancer recurrence after colon cancer resection. Dig Surg 37 (2020), 163–170.
16. Abu-Ghanem, Y., Dotan, Z., Zilberman, D.E., Kaver, I., Ramon, J., Intraoperative but not postoperative blood transfusion adversely affect cancer recurrence and survival following nephrectomy for renal cell carcinoma. Sci Rep, 9, 2019 Feb 4, 1160.
17. Kang, R., Seath, B.E., Huang, V., Barth, R.J. Jr., Impact of autologous blood transfusion on survival and recurrence among patients undergoing partial hepatectomy for colorectal cancer liver metastases. J Am Coll Surg 228 (2019 Jun), 902–908.
18. Schiergens, T.S., Rentsch, M., Kasparek, M.S., Frenes, K., Jauch, K.W., Thasler, W.E., Impact of perioperative allogeneic red blood cell transfusion on recurrence and overall survival after resection of colorectal liver metastases. Dis Colon Rectum 58 (2015 Jan), 74–82.
19. Tai, Y.H., Wu, H.L., Mandell, M.S., Tsou, M.Y., Chang, K.Y., The association of allogeneic blood transfusion and the recurrence of hepatic cancer after surgical resection. Anaesthesia 75 (2020 Apr), 464–471.
20. Shiba, H., Ishida, Y., Wakiyama, S., Iida, T., Matsumoto, M., Sakamoto, T., et al. Negative impact of blood transfusion on recurrence and prognosis of hepatocellular carcinoma after hepatic resection. J Gastrointest Surg 13 (2009 Sep), 1636–1642.
21. Liu, B., Teng, F., Fu, H., Guo, W.Y., Shi, X.M., Ni, Z.J., et al. Excessive intraoperative blood loss independently predicts recurrence of hepatocellular carcinoma after liver transplantation. BMC Gastroenterol, 15, 2015 Oct 15, 138.
22. Araujo, R.L., Pantanali, C.A., Haddad, L., Rocha Filho, J.A., D'Albuquerque, L.A., Andraus, W., Does autologous blood transfusion during liver transplantation for hepatocellular carcinoma increase risk of recurrence?. World J Gastrointest Surg 8 (2016 Feb 27), 161–168.
23. Han, S., Kim, G., Ko, J.S., Sinn, D.H., Yang, J.D., Joh, J.W., et al. Safety of the use of blood salvage and autotransfusion during liver transplantation for hepatocellular carcinoma. Ann Surg 264 (2016 Aug), 339–343.
24. Wu, W.W., Zhang, W.Y., Zhang, W.H., Yang, L., Deng, X.Q., Ou, M.C., et al. Survival analysis of intraoperative blood salvage for patients with malignancy disease: a prisma-compliant systematic review and meta-analysis. Medicine (Baltim), 98, 2019 Jul, e16040.
25. Åberg, F., Isoniemi, H., Höckerstedt, K., Long-term results of liver transplantation. Scand J Surg 100 (2011), 14–21.
26. Pfitzmann, R., Nüssler, N.C., Hippler-Benscheidt, M., Neuhaus, R., Neuhaus, P., Long-term results after liver transplantation. Transpl Int 21 (2008 Mar), 234–246.
27. Rubín, A., Sánchez-Montes, C., Aguilera, V., Juan, F.S., Ferrer, I., Moya, A., et al. Long-term outcome of 'long-term liver transplant survivors'. Transpl Int 26 (2013 Jul), 740–750.
28. Goubran, H.A., Elemary, M., Radosevich, M., Seghatchian, J., El-Ekiaby, M., Burnouf, T., Impact of transfusion on cancer growth and outcome. Canc Growth Metastasis 9 (2016), 1–8.
29. Tzounakas, V.L., Seghatchian, J., Grouzi, E., Kokoris, S., Antonelou, M.H., Red blood cell transfusion in surgical cancer patients: targets, risks, mechanistic understanding and further therapeutic opportunities. Transfus Apher Sci 56 (2017 Jun), 291–304.
30. Catling, S., Williams, S., Freites, O., Rees, M., Davies, C., Hopkins, L., Use of a leucocyte filter to remove tumour cells from intra-operative cell salvage blood. Anaesthesia 63 (2008 Dec), 1332–1338.
31. Shukla, A., Vadeyar, H., Rela, M., Shah, S., Liver transplantation: east versus west. J Clin Exp Hepatol 3 (2013 Sep), 243–253.
32. Berenguer, M., Burra, P., Ghobrial, M., Hibi, T., Metselaar, H., Sapisochin, G., et al. Posttransplant management of recipients undergoing liver transplantation for hepatocellular carcinoma. Working group report from the ilts transplant oncology consensus conference. Transplantation 104 (2020 Jun), 1143–1149.